Cidara Therapeutics Inc (CDTX)

May 16, 2025

When (CDTX) Moves Investors should Listen - news.stocktradersdaily.com

May 16, 2025

May 16, 2025

Cidara Therapeutics (CDTX) Target Price Raised by Guggenheim | CDTX Stock News - GuruFocus

May 16, 2025

May 16, 2025

Cidara Therapeutics (CDTX) Target Price Raised to $50 by Guggenh - GuruFocus

May 16, 2025

May 16, 2025

Cidara Therapeutics (CDTX) Target Price Raised to $50 by Guggenheim | CDTX Stock News - GuruFocus

May 16, 2025

May 16, 2025

Cidara Therapeutics price target raised to $50 from $35 at Guggenheim - TipRanks

May 16, 2025

May 15, 2025

Cidara Therapeutics to Host Virtual R&D Day to Discuss - GlobeNewswire

May 15, 2025

May 15, 2025

Revolutionary Once-Per-Year Universal Flu Prevention: Cidara Unveils Phase 2b Trial Updates at R&D Day - Stock Titan

May 15, 2025

May 13, 2025

Cidara Therapeutics to Participate in Two Upcoming Investor Conferences - GlobeNewswire

May 13, 2025

May 12, 2025

Cidara Therapeutics’ CD388 Progress and Challenges Highlighted in Earnings Call - MSN

May 12, 2025

May 12, 2025

Cidara Therapeutics (NASDAQ:CDTX) Price Target Raised to $35.00 - Defense World

May 12, 2025

May 11, 2025

Cidara Therapeutics, Inc. (NASDAQ:CDTX) Q1 2025 Earnings Call Transcript - Insider Monkey

May 11, 2025

May 11, 2025

Cidara Therapeutics (NASDAQ:CDTX) Stock Price Expected to Rise, JMP Securities Analyst Says - Defense World

May 11, 2025

May 10, 2025

Guggenheim Raises Price Target for Cidara Therapeutics (CDTX) to $35.00 | CDTX Stock News - GuruFocus

May 10, 2025

May 10, 2025

StockNews.com Upgrades Cidara Therapeutics (NASDAQ:CDTX) to Sell - Defense World

May 10, 2025

May 09, 2025

Cidara Therapeutics (CDTX) Target Price Raised by JMP Securities - GuruFocus

May 09, 2025

May 09, 2025

Cidara Therapeutics (CDTX) Target Price Raised by JMP Securities | CDTX Stock News - GuruFocus

May 09, 2025

May 09, 2025

RBC Cuts Price Target on Cidara Therapeutics to $31 From $34, Keeps Outperform, Speculative Risk - marketscreener.com

May 09, 2025

May 09, 2025

Cidara Therapeutics (CDTX) Target Price Raised to $35 by Guggenheim | CDTX Stock News - GuruFocus

May 09, 2025

May 09, 2025

Cidara Therapeutics (CDTX) Sees Price Target Increase by Citizens JMP | CDTX Stock News - GuruFocus

May 09, 2025

May 09, 2025

Cidara Therapeutics: Q1 Earnings Snapshot - New Haven Register

May 09, 2025

May 09, 2025

Cidara Therapeutics Inc (CDTX) Q1 2025 Earnings Call Highlights: Promising Advances in ... - Yahoo Finance

May 09, 2025

May 09, 2025

Cidara Therapeutics Inc (CDTX) Q1 2025 Earnings Call Highlights: Promising Advances in Influenza Prevention Amid Financial Challenges - GuruFocus

May 09, 2025

May 09, 2025

Cidara Therapeutics Reports Q1 2025 Financial Results - TipRanks

May 09, 2025

May 08, 2025

CDTX Targets Key Data Release for Influenza Treatment by Mid-202 - GuruFocus

May 08, 2025

May 08, 2025

Cidara Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 08, 2025

May 08, 2025

CDTX Targets Key Data Release for Influenza Treatment by Mid-2025 | CDTX Stock News - GuruFocus

May 08, 2025

May 08, 2025

Cidara Therapeutics reports Q1 EPS ($1.66) vs. ($2.28) last year - TipRanks

May 08, 2025

May 08, 2025

Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results | CDTX Stock News - GuruFocus

May 08, 2025

May 08, 2025

Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results - The Manila Times

May 08, 2025

May 06, 2025

(CDTX) Investment Report - news.stocktradersdaily.com

May 06, 2025

May 05, 2025

Cidara Therapeutics: Strong Buy On Imminent Data Readout For Lead Flu Candidate (CDTX) - Seeking Alpha

May 05, 2025

May 02, 2025

Nicole Davarpanah named Cidara CMO - The Pharma Letter

May 02, 2025

May 02, 2025

Candidiasis Pipeline: 15+ Key Innovators Advancing - openPR.com

May 02, 2025

May 02, 2025

Cidara Therapeutics (CDTX) Announces Key Leadership Promotions | - GuruFocus

May 02, 2025

May 02, 2025

Cidara Therapeutics, Inc. (NASDAQ:CDTX) Given Average Recommendation of “Buy” by Brokerages - Defense World

May 02, 2025

May 02, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

May 02, 2025

May 01, 2025

Cidara Therapeutics Names Nicole Davarpanah as Chief Medical Officer - marketscreener.com

May 01, 2025

May 01, 2025

Cidara Therapeutics (CDTX) Announces Key Leadership Promotions | CDTX Stock News - GuruFocus

May 01, 2025

May 01, 2025

Cidara Therapeutics appoints new CMO and SVP By Investing.com - Investing.com India

May 01, 2025

May 01, 2025

Cidara Therapeutics appoints new CMO and SVP - Investing.com

May 01, 2025

May 01, 2025

Cidara Therapeutics Announces Promotion of Nicole Davarpanah to Chief Medical Officer and Corrina Pavetto to SVP, Clinical Development - The Manila Times

May 01, 2025

May 01, 2025

Cidara Therapeutics Announces Promotion of Nicole - GlobeNewswire

May 01, 2025

May 01, 2025

Cidara Therapeutics (NASDAQ:CDTX) Earns Market Outperform Rating from JMP Securities - Defense World

May 01, 2025

Apr 30, 2025

Are You Looking for a Top Momentum Pick? Why Cidara Therapeutics (CDTX) is a Great Choice - Yahoo Finance

Apr 30, 2025

Apr 30, 2025

Cidara Therapeutics to Participate in The Citizens Life Sciences Conference - GlobeNewswire

Apr 30, 2025

Apr 30, 2025

Cantor Fitzgerald raises Cidara stock to Overweight - MSN

Apr 30, 2025

Apr 29, 2025

JMP maintains $46 target on Cidara stock ahead of Phase 2b results - Investing.com Canada

Apr 29, 2025